ALHAMBRA, Calif., Nov. 21, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana"), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, is proud to announce that eight of its affiliates have been recognized as Elite status recipients in the 2024 Standards of Excellence™ (SOE®) survey by America's Physician Groups (APG). This annual comprehensive survey is administered by APG to evaluate which physician groups are best positioned to provide coordinated, patient-centered, and cost-effective care.

ALHAMBRA, Calif., Nov. 8, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it and its affiliated professional entities have entered into a definitive agreement to acquire Prospect Health ("Prospect"), which consists of certain businesses and assets relating to Prospect Health System, including its California licensed health care service plan (Prospect Health Plan), medical groups in California, Texas, Arizona and Rhode Island (Pro

Company to Host Conference Call on Thursday, November 7, 2024, at 2:30 p.m. PT/5:30 p.m. ET ALHAMBRA, Calif., Nov. 7, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced its consolidated financial results for the third quarter ended September 30, 2024. "Astrana's strong third quarter continues to reflect the outcomes we are

ALHAMBRA, Calif., Oct. 23, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the third quarter ended September 30, 2024, after the close of the stock market on Thursday, November 7, 2024. The Company will discuss those results on a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day.

ALHAMBRA, Calif., Oct. 7, 2024 /PRNewswire/ --– Astrana Health, Inc. ("Astrana"), together with its subsidiaries and affiliated entities ("the Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced it has closed its transaction to acquire Collaborative Health Systems ("CHS"), a management services organization serving more than 129,000 beneficiaries across 17 states and previously a company of Centene Corporation (NYSE:CNC) ("Centene"), a leading healthcare enterprise focused on transforming the health of the communities it serves.

ALHAMBRA, Calif., Aug. 22, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that leadership is participating in the following upcoming investor conferences: The Wells Fargo Healthcare Conference, being held in Boston, on Wednesday, September 4, 2024.The Morgan Stanley 22nd Annual Global Healthcare Conference, being held

Company to Host Conference Call on Wednesday, August 7, 2024, at 2:30 p.m. PT/5:30 p.m. ET ALHAMBRA, Calif., Aug. 7, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced its consolidated financial results for the second quarter ended June 30, 2024. "We believe our strong second quarter results and entry into new states refle

ALHAMBRA, Calif., July 25, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana"), together with its subsidiaries and affiliated entities ("the Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced it has entered into a definitive agreement to acquire Collaborative Health Systems ("CHS"), a management services organization serving more than 129,000 beneficiaries across 17 states and a company of Centene Corporation (NYSE:CNC) ("Centene"), a leading healthcare enterprise focused on transforming the health of the communities it serves. The acquisition facilita

ALHAMBRA, Calif., July 23, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the second quarter ended June 30, 2024, after the close of the stock market on Wednesday, August 7, 2024. The Company will discuss those results on a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day.

Partnership Will First Launch Value-Based Care Solution Offering to Hawai'i Provider Community ALHAMBRA, Calif., July 17, 2024 /PRNewswire/ -- Astrana Health, Inc. (together with its subsidiaries and affiliated entities, "Astrana") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced a strategic partnership with Elation Health, the clinical-first technology company powering innovation in primary care with more than 32,000 clinicians caring for over 15 million patients using its electronic health record ("EHR") platform.

TD Cowen initiated coverage of Astrana Health with a rating of Buy and set a new price target of $66.00

KeyBanc Capital Markets initiated coverage of Astrana Health with a rating of Sector Weight

Truist upgraded Astrana Health from Hold to Buy and set a new price target of $50.00 from $44.00 previously

Robert W. Baird initiated coverage of Astrana Health with a rating of Outperform and set a new price target of $54.00

4 - Astrana Health, Inc. (0001083446) (Issuer)

4 - Astrana Health, Inc. (0001083446) (Issuer)

4 - Astrana Health, Inc. (0001083446) (Issuer)

4 - Astrana Health, Inc. (0001083446) (Issuer)

4 - Astrana Health, Inc. (0001083446) (Issuer)

4 - Astrana Health, Inc. (0001083446) (Issuer)

4 - Astrana Health, Inc. (0001083446) (Issuer)

4 - Astrana Health, Inc. (0001083446) (Issuer)

4 - Astrana Health, Inc. (0001083446) (Issuer)

4 - Astrana Health, Inc. (0001083446) (Issuer)

8-K - Astrana Health, Inc. (0001083446) (Filer)

8-K - Astrana Health, Inc. (0001083446) (Filer)

10-Q - Astrana Health, Inc. (0001083446) (Filer)

8-K - Astrana Health, Inc. (0001083446) (Filer)

8-K - Astrana Health, Inc. (0001083446) (Filer)

8-K - Astrana Health, Inc. (0001083446) (Filer)

8-K - Astrana Health, Inc. (0001083446) (Filer)

8-K - Astrana Health, Inc. (0001083446) (Filer)

10-Q - Astrana Health, Inc. (0001083446) (Filer)

8-K - Astrana Health, Inc. (0001083446) (Filer)

ALHAMBRA, Calif., Nov. 8, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it and its affiliated professional entities have entered into a definitive agreement to acquire Prospect Health ("Prospect"), which consists of certain businesses and assets relating to Prospect Health System, including its California licensed health care service plan (Prospect Health Plan), medical groups in California, Texas, Arizona and Rhode Island (Pro

Company to Host Conference Call on Thursday, November 7, 2024, at 2:30 p.m. PT/5:30 p.m. ET ALHAMBRA, Calif., Nov. 7, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced its consolidated financial results for the third quarter ended September 30, 2024. "Astrana's strong third quarter continues to reflect the outcomes we are

ALHAMBRA, Calif., Oct. 23, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the third quarter ended September 30, 2024, after the close of the stock market on Thursday, November 7, 2024. The Company will discuss those results on a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day.

Company to Host Conference Call on Wednesday, August 7, 2024, at 2:30 p.m. PT/5:30 p.m. ET ALHAMBRA, Calif., Aug. 7, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced its consolidated financial results for the second quarter ended June 30, 2024. "We believe our strong second quarter results and entry into new states refle

ALHAMBRA, Calif., July 23, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the second quarter ended June 30, 2024, after the close of the stock market on Wednesday, August 7, 2024. The Company will discuss those results on a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day.

Company to Host Conference Call on Tuesday, May 7, 2024, at 2:30 p.m. PT/5:30 p.m. ET ALHAMBRA, Calif., May 7, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced its consolidated financial results for the first quarter ended March 31, 2024. "We believe our strong first quarter performance continues to demonstrate the uniqu

ALHAMBRA, Calif., April 30, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the first quarter ended March 31, 2024, after the close of the stock market on Tuesday, May 7, 2024. The Company will discuss those results on a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day.

Expands Payer-Agnostic Care Delivery Capabilities Serving Over 129,000 Beneficiaries Across 17 States

Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, Anthem Blue Cross, one of California's largest health insurers, and Allied Pacific IPA, part of Astrana Health, a leading independent physician association serving the California community since 1992, today announced a new partnership aimed at improving access to high-quality healthcare for their shared members.This partnership underscores both organizations' commitment to increasing access to care by addressing social and health i

Truist Securities upgraded Astrana Health Inc (NASDAQ:ASTH), a technology-powered healthcare company. Astrana serves over 10,000 providers and 1.0 million patients in value-based care arrangements. With Astrana Health reporting lower trends than peers in the space, Truist wrote the company’s care model has potentially captured “pent-up” demand, adversely impacting the value-based care industry. Thanks to its comprehensive delegation model, the Truist analyst was more confident in the company’s ability to manage utilization and monitor trends. Truist pointed out several underappreciated tailwinds for Astrana, including: Astrana has a significant presence in Southern California

Shares of Conagra Brands, Inc. (NYSE:CAG) fell during Thursday's session after the company reported worse-than-expected fourth-quarter sales results and issued FY25 adjusted EPS guidance below estimates. The company reported adjusted earnings per share of 61 cents, beating the analyst consensus estimate of 57 cents. Quarterly revenues of $2.905 billion missed the street view of $2.930 billion, according to data from Benzinga Pro. Conagra Brands shares declined 3.9% to $27.70 on Thursday. Here are some other stocks moving in today’s mid-day session. Gainers Kazia Therapeutics Limited (NASDAQ:KZIA) shares surged 88.6% to $1.26. Kazia Therapeutics, on Wednesday, announced result

U.S. stocks were mostly higher, with the Dow Jones index gaining around 100 points on Thursday. Shares of Methode Electronics, Inc. (NYSE:MEI) rose sharply during Thursday's session after the company reported better-than-expected fourth-quarter sales results. Methode Electronics reported a fourth-quarter fiscal 2024 net sales decline of 7.9% year-on-year to $277.30 million, beating the analyst consensus estimate of $264.04 million. Adjusted EPS loss of 23 cents missed the analyst consensus loss estimate of 20 cents, according to data from Benzinga Pro. Methode Electronics shares surged 29.4% to $12.22 on Thursday. Here are some other big stocks recording gains in today’s session.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Morgan Stanley cut the price target for Microchip Technology Incorporated (NASDAQ:MCHP) from $102 to $100. Morgan Stanley analyst Joseph Moore downgraded the stock from Overweight to Equal-Weight. Microchip Technology shares rose 3.9% to close at $95.98 on Wednesday. See how other analysts view this stock. Truist Securities lifted the price target for Astrana Health, Inc. (NASDAQ:ASTH) from $44 to $50. Truist Securities analyst Jailendra Singh upgraded the stock from Hold to Buy. Astrana Health sha

Truist Securities analyst Jailendra Singh upgrades Astrana Health (NASDAQ:ASTH) from Hold to Buy and raises the price target from $44 to $50.

Stifel analyst Chris O'Cull maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the price target from $45 to $48.

Baird analyst Michael Ha initiates coverage on Astrana Health (NASDAQ:ASTH) with a Outperform rating and announces Price Target of $54.